Micro-EMG: A Novel Multi-electrode System for Intramuscular Imaging
Launched by NEWCASTLE UNIVERSITY · Jan 26, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new system called Micro-EMG, which uses multiple small electrodes to look at muscle activity in a way that could help doctors better understand and diagnose muscle and nerve conditions. The goal of this study is to gather important information about how well this system works before larger studies are done to confirm its effectiveness.
To participate, you need to be between the ages of 65 and 74, and they are looking for a total of 30 people. However, some individuals may not be eligible if they have certain medical devices like pacemakers, specific neurological disorders, or conditions that affect blood clotting. If you join, you can expect to undergo tests that will help researchers learn more about how to use this new technology safely and effectively. Your participation could play a key role in advancing the way muscle and nerve conditions are diagnosed and treated in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • For each of the five groups, six participants will be recruited, adding up to a total of 30 participants.
- Exclusion Criteria:
- • cardiac pacemakers or defibrillator implants.
- • alternative neurological disorders likely to affect the results of an EMG examination.
- • lymphedema or dialysis fistula in the body region to be studied with EMG.
- • patients taking clotting inhibitor (such as warfarin or direct oral anticoagulants).
- • clotting disorder (such as haemophilia or low platelets).
- • participants unable to consent in English where a translator is not available.
About Newcastle University
Newcastle University is a leading research institution located in the United Kingdom, renowned for its commitment to advancing healthcare through innovative clinical trials and scientific research. The university's Clinical Trials Unit plays a pivotal role in the design, coordination, and execution of high-quality clinical studies, focusing on a wide range of therapeutic areas. With a multidisciplinary team of experts, Newcastle University fosters collaboration between academia, industry, and healthcare providers, ensuring that research findings translate into meaningful advancements in patient care. Its dedication to excellence and ethical standards positions Newcastle University as a trusted sponsor in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, , United Kingdom
Patients applied
Trial Officials
Roger Whittaker
Principal Investigator
Newcastle University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials